オレゴンにおける食道腺癌の臨床試験
オレゴン内の拠点で、食道腺癌に関する6件の研究が参加者を募集しています。
オレゴン内の都市
公式研究テキスト（英語）
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Clackamas Radiation Oncology Center, Clackamas
- Providence Newberg Medical Center, Newberg
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Oncology Associates Of Oregon, Pc, Eugene
- Northwest Cancer Specialists, P.C., Portland
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Portland
- Research Site, Portland
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Providence Cancer Institute Franz Clinic, Portland
- Providence Oncology and Hematology Care Clinic - Westside, Portland
- Providence St. Vincent Medical Center- Investigational Drug Services, Portland
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- VA Portland Health Care System, Portland, OR, Portland
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/05更新 · NCT05563766ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。